Cuu Long Pharmaceutical JSC (HOSE: DCL)
27,000
Open27,350
High27,650
Low26,800
Vol366,500
Market Cap.1,972.11
Remain Bid9,800
Remain Ask15,500
52Wk High29,200
52Wk Low22,000
52Wk Avg Vol102,010
Foreign Buy-
Frgn Owned(%)1.19
Dividend
Dividend Yield-
Beta0.81
EPS948
P/E28.78
F P/E15.61
BVPS20,266
P/B1.35
Date | Close | Change | Volume |
---|---|---|---|
05/03/2024 | 27,000 | -300 (-1.10%) | 366,500 |
05/02/2024 | 27,300 | 0 (0.00%) | 394,000 |
04/26/2024 | 27,300 | 0 (0.00%) | 210,100 |
04/25/2024 | 27,300 | 50 (+0.18%) | 296,300 |
04/24/2024 | 27,250 | 1,250 (+4.81%) | 250,000 |
07/13/2023 | DCL: DCL signs Auditing Contract |
05/17/2023 | DCL: Approving the transaction with related parties |
04/19/2023 | DCL: Resolution on the AGM 2023 |
04/14/2023 | DCL: Stop planning to issue shares under ESOP |
03/31/2023 | DCL: Information on the appellate court |
06/22/2018 | DCL 2017's Dividend payment in cash with 5% (Record date) |
06/22/2018 | DCL 2017's Dividend payment in cash with 5% |
07/15/2015 | DCL Buying addition shares with 1:1 and VND 20,000/share (Record date) |
05/28/2014 | DCL 2013's Dividend payment in cash with 6% (Record date) |
05/28/2014 | DCL 2013's Dividend payment in cash with 6% |
04/26/2024 | Resolution of Annual Shareholders' Meeting 2024 |
04/24/2024 | Explanation for FS Quarter 1 of 2024 |
04/24/2024 | Parent Company FS Quarter 1 of 2024 |
04/24/2024 | Consolidated FS Quarter 1 of 2024 |
03/28/2024 | 2024 Annual Shareholders’Meeting Documents |
Name: Cuu Long Pharmaceutical JSC
Abbreviation:VPC
Address: 150 Street 14/9, Ward 5 Vinh Long Vinh Long
Telephone: (84.270) 382 2533
Fax: (84.270) 382 2129
Email:contact@dcl.vn
Website:http://dcl.com.vn
Exchange: HOSE
Sector: Manufacturing
Industry: Chemical - Pharmaceutical
Listing date: 09/17/2008
Chartered capital: 730,410,300,000
Listed shares: 73,041,030
Shares outstanding: 73,041,030
Status: Operating
Tax code: 1500202535
Establishment license: 2314/QÐUB
Issued date: 08/09/2004
Business license: 5403000021
Issued date: 11/09/2004
Main business scope:
- Manufacturing, merchandising, import and export of pharmaceutical drugs, capsules, medical equipment for pharmacy, healthcare.
- Production of health food, cosmetics, and other chemicals for pharmaceutical production.
- Production of packaging for drugs and medical products.
- Cultivation of traditional herbs.
- Other areas under business license.
Branches:
In Laos:
Add: 011 Lanexang St.- B.Hatsady - Chanthaboury District - Vientaine - Lao P.D.R
Tel: (00.856.21)243624
Fax: (00.856.21)243625
- 1976: Cuu Long Pharmaceutical Enterprise and Cuu Long Pharmaceutical Company were established.
- 1984: Cuu Long Pharmaceutical Enterprise and Cuu Long Pharmaceutical Company merged to become Cuu Long Pharmaceutical Association Enterprise.
- 1992:Cuu Long Pharmaceutical Association Enterprise was divided into Tra Vinh Pharmaceutical Company and Cuu Long Pharmaceutical Company.
- 1992: Cuu Long Pharmaceutical Company was renamed as Cuu Long Pharmaceutical & Healthcare Equipment Company.
- 2004:Cuu Long Pharmaceutical & Healthcare Equipment Company was changed to Cuu Long Pharmaceutical Joint Stock Corporation (DCL) with the initial charter capital of VND56 billion.
- 2008: Company's stock (code DCL) was officially listed on HOSE.
- 2010: Raised charter capital to VND99 billion;
- 2011: Raised charter captial to VND100 billion;
- 15 November 2017: Charter capital was raised up to VND568,328,240,000.
- 21 September 2021: Increased charter capital to VND588,328,240,000;
- 09/09/2024 DCL Annoucement of the change of listing - 254,200 shares
- 04/25/2024 DCL General Meeting of Shareholders for 2024
- 03/16/2023 DCL Annoucement of the change of listing - 14,208,206 shares
- 09/07/2022 DCL Annoucement of the change of listing - 1,745,800 shares
- 06/14/2022 DCL General Meeting of Shareholders for 2022
Items | Unit |
---|---|
Price | VND |
Volume | Shares |
Foreigner's, Yield | % |
Mkt Cap | bVND |
Financial indicators | mVND |
EPS, BVPS, Dividend | VND |
P/E, F P/E, P/B | Times |
ROS, ROA, ROE | % |
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.